Logo image of BIOL

BIOLASE INC (BIOL) Stock Analyst Earnings Estimates

NASDAQ:BIOL - Nasdaq - US0909117022 - Common Stock - Currency: USD

0.129  -0.02 (-13.19%)

After market: 0.109 -0.02 (-15.5%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025
Revenue
YoY % growth
BIOL revenue by date.BIOL revenue by date.
39.19M
72.04%
48.46M
23.65%
49.164M
1.45%
51.687M
5.13%
55.72M
7.80%
EBITDA
YoY % growth
BIOL ebitda by date.BIOL ebitda by date.
-15.72M
12.86%
-24.84M
-58.02%
-15.139M
39.05%
-4.794M
68.33%
-306K
93.62%
EBIT
YoY % growth
BIOL ebit by date.BIOL ebit by date.
-16.12M
13.05%
-25.34M
-57.20%
-17.937M
29.21%
-7.863M
56.16%
-5.035M
35.96%
Operating Margin
BIOL operating margin by date.BIOL operating margin by date.
-41.13%-52.29%-36.48%-15.21%-9.04%
EPS
YoY % growth
BIOL eps by date.BIOL eps by date.
-3.25
62.86%
-410.00
-12,515.38%
-31.89
92.22%
-0.45
98.59%
-0.10
78.41%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth
-0.07
98.30%
-0.03
98.26%
-0.06
83.00%
-0.01
87.25%
-0.02
69.23%
-0.03
Revenue
Q2Q % growth
11.81M
8.14%
15.637M
15.92%
10.71M
5.72%
15.606M
35.00%
12.954M
9.69%
16.473M
5.35%
EBITDA
Q2Q % growth
-918K
41.53%
1.071M
147.01%
-2.652M
31.40%
-816K
-23.08%
-1.224M
-33.33%
1.734M
61.90%
EBIT
Q2Q % growth
-1.839M
50.30%
372.637K
107.34%
-2.601M
42.53%
-816K
50.41%
-1.173M
36.21%
153K
-58.94%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2024
Q2Q % growth
-0.08
99.03%
-0.080.00-4.58%
Q1 2024
Q2Q % growth
-0.36
98.00%
-0.17-0.19-107.61%
Q4 2023
Q2Q % growth
-1.76
98.63%
-2.610.8532.47%
Q3 2023
Q2Q % growth
-3.89
96.46%
-1.89-2.00-106.15%
Q2 2023
Q2Q % growth
-8.24
90.95%
-5.44-2.80-51.48%
Q1 2023
Q2Q % growth
-18.00
77.78%
-20.062.0610.27%
Q4 2022
Q2Q % growth
-128.00
-16,966.67%
-64.94-63.06-97.10%
Q3 2022
Q2Q % growth
-110.00
-21,900.00%
-86.02-23.98-27.88%
Q2 2022
Q2Q % growth
-91.00
-18,100.00%
-63.50-27.50-43.32%
Q1 2022
Q2Q % growth
-81.00
-5,300.00%
-69.36-11.64-16.78%
Q4 2021
Q2Q % growth
-0.75
57.14%
-0.64-0.11-17.65%
Q3 2021
Q2Q % growth
-0.50
60.00%
-0.700.2028.70%
Q2 2021
Q2Q % growth
-0.50
83.33%
-1.100.6054.75%
Q1 2021
Q2Q % growth
-1.50
45.45%
-1.28-0.23-17.65%
Q4 2020
Q2Q % growth
-1.75
-40.00%
-0.94-0.81-87.15%
Q3 2020
Q2Q % growth
-1.25
58.33%
-1.360.118.08%
Q2 2020
Q2Q % growth
-3.00
7.69%
-4.341.3430.80%
Q1 2020
Q2Q % growth
-2.75
26.67%
-4.251.5035.30%
Q4 2019
Q2Q % growth
-1.25 -1.280.021.96%
Q3 2019
Q2Q % growth
-3.00 -3.490.4913.92%
Q2 2019
Q2Q % growth
-3.25 -3.14-0.11-3.34%
Q1 2019
Q2Q % growth
-3.75 -4.670.9219.78%
BIOL Yearly EPS VS EstimatesBIOL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -200 -400 -600 -800 -1K
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2024
Q2Q % growth
11.56M
-19.08%
13.765M-2.205M-16.02%
Q1 2024
Q2Q % growth
10.131M
-3.21%
10.196M-65K-0.64%
Q4 2023
Q2Q % growth
13.49M
-3.99%
13.82M-330K-2.39%
Q3 2023
Q2Q % growth
10.921M
-9.07%
14.237M-3.316M-23.29%
Q2 2023
Q2Q % growth
14.286M
16.72%
15.664M-1.378M-8.80%
Q1 2023
Q2Q % growth
10.467M
2.92%
10.382M85K0.82%
Q4 2022
Q2Q % growth
14.05M
13.22%
14.349M-299K-2.08%
Q3 2022
Q2Q % growth
12.01M
26.02%
10.867M1.143M10.52%
Q2 2022
Q2Q % growth
12.24M
34.06%
10.84M1.4M12.92%
Q1 2022
Q2Q % growth
10.17M
25.25%
9.192M978K10.64%
Q4 2021
Q2Q % growth
12.41M
45.66%
12.215M195K1.60%
Q3 2021
Q2Q % growth
9.53M
45.72%
8.958M572K6.39%
Q2 2021
Q2Q % growth
9.13M
210.54%
8.472M658K7.77%
Q1 2021
Q2Q % growth
8.12M
69.87%
7.95M170K2.14%
Q4 2020
Q2Q % growth
8.52M
-16.31%
8.502M18K0.21%
Q3 2020
Q2Q % growth
6.54M
-24.39%
6.631M-91K-1.37%
Q2 2020
Q2Q % growth
2.94M
-66.01%
2.129M811K38.09%
Q1 2020
Q2Q % growth
4.78M
-53.73%
5.076M-296K-5.83%
Q4 2019
Q2Q % growth
10.18M 13.595M-3.415M-25.12%
Q3 2019
Q2Q % growth
8.65M 9.685M-1.035M-10.69%
Q2 2019
Q2Q % growth
8.65M 12.836M-4.186M-32.61%
Q1 2019
Q2Q % growth
10.33M 10.639M-309K-2.90%
BIOL Yearly Revenue VS EstimatesBIOL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-50% 84.04% -37.5% 76.15%
Revenue-4.26% -8.58% -1.61% -4.51%